KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $46.0 million.

  • Organon's Capital Expenditures rose 952.38% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.0 million, marking a year-over-year decrease of 1356.78%. This contributed to the annual value of $175.0 million for FY2024, which is 3027.89% down from last year.
  • Latest data reveals that Organon reported Capital Expenditures of $46.0 million as of Q3 2025, which was up 952.38% from $39.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Capital Expenditures ranged from a high of $79.0 million in Q4 2023 and a low of $32.0 million during Q2 2024
  • Moreover, its 5-year median value for Capital Expenditures was $46.0 million (2023), whereas its average is $49.0 million.
  • As far as peak fluctuations go, Organon's Capital Expenditures skyrocketed by 5777.78% in 2023, and later plummeted by 5492.96% in 2024.
  • Quarter analysis of 5 years shows Organon's Capital Expenditures stood at $59.0 million in 2021, then rose by 6.78% to $63.0 million in 2022, then increased by 25.4% to $79.0 million in 2023, then tumbled by 30.38% to $55.0 million in 2024, then decreased by 16.36% to $46.0 million in 2025.
  • Its last three reported values are $46.0 million in Q3 2025, $39.0 million for Q2 2025, and $32.0 million during Q1 2025.